top of page
Establishes terms of collaboration between FDA and UMD to support shared interest in scientific progress through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships.
University of Maryland
OC Eileen Parish (301) 796-8522
2002-09-04
Indefinite
IL Inst. Tech., participation in short courses, workshops, & training programs in food safety and technology.
Illinois Institute of Technology
CFSAN Don Zink (240) 402-1693
1993-09-03
Indefinite
Establishes the terms for collaborative research between the FDA and Stanford University to promote scientific progress in animal and human medicine. Amended to change POC and termination date.
Stanford University
CDRH Anindita Saha (301-796-2537 Mimi Nguyen 301-796-4125
2012-07-12 Revised on 2016-05-11
Indefinite
Shared interests in promoting scientific progress through exchange of scientific capital in Clinical Pharmacology Training and Research Programs. This was amended to extend the termination date to June 30, 2021.
University of California at San Diego
CDER 
2012-06-30 Revised on: 2018-05-08, 2021-08-06
2026-08-06
Shared interests in promoting scientific progress through exchange of scientific capital in Clinical Pharmacology Training and Research Programs.  Replaced MOU 225-11-0006.
University of California San Francisco
CDER Padmaja Mummaneni, 301-796-2027
2016-10-9
2021-10-08
Promote scientific progress through exchange of scientific capital to enhance the assessment of safety and efficacy of FDA-regulated products through joint educational and training fellowship programs.
Duke University
CDER Padmaja Mummaneni, PhD 301-796-2027   
2017-08-03-
2022-08-02
This MOU establishes the terms for collaboration to promote shared interests, which can be pursued through a variety of programs including collaborative education and research.
University of California San Francisco (UCSF)
Padmaja Mummaneni, PhD. Office of Translational Sciences
2024-03-11
2029-03-11
This MOU documents affiliation among Walter Reed, Uniformed Services University, and FDA in the established Clinical Pharmacology Fellowship Training Program.
Walter Reed, Uniformed Services University, and FDA
Padmaja Mummaneni, PhD. Office of Translational Sciences (OTS)
2024-02-05
2032-07-01
This MOU establishes the terms for collaboration to promote  FDA and MSU’s shared interests, which can be pursued through a variety of programs.
Michigan State University (MSU)
CDER Padmaja Mummaneni, PhD (301) 796-2027
2023-08-01
2028-08-01
Establishes the FDA-ASA Oncology Educational Fellowship. Both parties share interests in promoting scientific progress through exchange of scientific knowledge in statistical methods for clinical research, oncology education, collaborative learning, and research.
American Statistical Association (ASA)
Oncology Center of Excellence (OCE) Jennifer Gao M.D.  Associate Director for Education  10903 New Hampshire Ave, WO 22/2135  Silver Spring, MD 20993 Jennifer.gao@fda.hhs.gov  240-402-4683
2023-06-06
2028-09-30
This MOU forms the basis for development of scientific collaborations, outreach and educational initiatives and intellectual partnerships between FDA and University of Pennsylvania, Perelman School of Medicine.
Perelman School of Medicine at the University of Pennsylvania (Penn Med)
Padmaja Mummaneni, Ph.D. Consumer Safety Officer, Regulatory Health Project Manager Center for Drug Evaluation and Research (CDER), Office of Translational Sciences, Office of Clinical Pharmacology 301-796-2027
2023-05-30
2028-05-30
The Food and Drug Administration’s (FDA) Oncology Center of Excellence (OCE), the American Association for Cancer Research (AACR), Oncology Nursing Society (ONS) and Hematology/Oncology Pharmacy Association (HOPA) agree to collaborate in Project Livin’ Label, a new educational initiative aimed at increasing awareness of recent FDA oncology drug approvals and understanding of the associated drug product label. The FDA, AACR, ONS and HOPA share interests in promoting scientific progress through exchange of scientific capital in oncology education, collaborative learning, and research. All institutions foresee benefits from collaborating in this new educational initiative focused on regulatory policy. This Memorandum of Understanding (MOU) establishes the terms for the collaboration for Project Livin’ Label and provides a basis for other related efforts to promote these shared, mutual interests in collaborative education and learning.
American Association for Cancer Research (AACR), Oncology Nursing Society (ONS) and Hematology/Oncology Pharmacy Association (HOPA)
Oncology Center of Excellence Laura B. Wisch Program Manager for Education 10903 New Hampshire Ave, WO 22/2135 Silver Spring, MD 20993Laura.Wisch@fda.hhs.gov 301-538-6580
2022-05-03
2027-05-03
bottom of page